02:00 AM EDT, 10/23/2026 (MT Newswires) -- BB Biotech (BION.SW) logged 175 million francs in profit for the third quarter, compared with 447.6 million francs a year ago. EPS moved to 3.17 francs from 8.16 francs year over year, a Friday filing showed. For the three months ended Sept. 30, operating income was 185.8 million francs versus 455.4 million francs previously, the Swiss biotechnology investment company added.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.